Practical considerations in the early treatment of ischemic stroke

American Family Physician

Volumn 57, Issue 1, 1998, Pages 73-80

  Broderick, Joseph P ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

CLINICAL PROTOCOL; EMERGENCY TREATMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; STROKE; TREATMENT OUTCOME; TREATMENT PLANNING;

ACUTE DISEASE; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; CRITICAL PATHWAYS; EMERGENCY SERVICE, HOSPITAL; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; PRACTICE GUIDELINES; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031906377     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Grotta J. Rodent models of stroke limitations. What can we learn from recent clinical trials of thrombolysis? Arch Neurol 1996;53:1067-70.
3. Sakurama T, Kitamura R, Kaneko M. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke. Stroke 1994;25:451-6.
4. Gross CE, Raymond SJ, Howard DB, Bednar MM. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke. Neurosurgery 1995;36:1172-7.
5. Zivin JA, Mazzarella V. Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch Neurol 1991;48:1235-8.
6. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
7. Barsan WG, Brott TG, Broderick JP, Haley EC, Levy DE, Marler JR. Time of hospital presentation in patients with acute stroke. Arch Intern Med 1993; 53:2558-61.
8. Feldmann E, Gordon N, Brooks JM, Brass IM, Fayad PB, Sawaya KL, et al. Factors associated with early presentation of acute stroke. Stroke 1993; 24:1805-10.
9. Morris D, Gorton R, Hinn A, et al. Delay in seeking care for stroke - demographic determinants: the delay in accessing stroke healthcare study. Society for Academic Emergency Medicine (SAEM) annual meeting. Denver, Colorado, May 5-8, 1996. Acad Emerg Med 1996;3:539.
10. Kothari R, Sauerbeck L, Jauch E, et al. Stroke victims: clueless. Society for Academic Emergency Medicine (SAEM) annual meeting. Denver, Colorado, May 5-8, 1996. Acad Emerg Med 1996; 3:538.
11. Spilker J. The importance of patient and public education in acute ischemic stroke. Proceedings from the National Symposium on Rapid Identification and Treatment of Acute Stroke, December 13, 1996. Washington, D.C.: National Institute of Neurological Disorders and Stroke (NINDS), 1997.
12. Genentech, Inc. National Registry of Myocardial Infarction II (NMRI II). Quarterly Data Report, Ohio data. September 1996.
13. National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group. Emergency department: rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med 1994;23:311-29.
14. Bratina P, Greenberg L, Pasteur W, Grotta JC. Current emergency department management of stroke in Houston, Texas. Stroke 1995;26:409-14.
15. Barsan W. Emergency department management of stroke. Proceedings from the National Symposium on Rapid Identification and Treatment of Acute Stroke, December 13, 1996. Washington, D.C.: National Institute of Neurological Disorders and Stroke (NINDS), 1997.
16. Brott T. Thrombolysis for stroke. Arch Neurol 1996; 53:1305-6.
17. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-18.